GlassScriptPhysician profile
Ari Kriswari
NPI 1164657870
$3,671.38
in general payments reported to CMS, 2019-2025
18 companies · $167 in 2025
The $167 reported for 2025 was more than what a typical Physical Medicine & Rehabilitation provider received nationally (typical 2025 total: $138).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,551 · 2020: $49.60 · 2021: $19.19 · 2022: $1,154 · 2023: $353 · 2024: $378 · 2025: $167.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $898.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $898.14 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $1,134.41 | 2022-2025 | Synchromedii |
| Medtronic USA, INC. | $1,133.50 | 2019-2020 | |
| Abbvie INC. | $491.26 | 2022-2025 | |
| Allergan, INC. | $203.08 | 2019-2021 | |
| Merz Pharmaceuticals, LLC | $179.59 | 2023-2025 | Xeomin |
| Merz North America, INC. | $144.94 | 2019 | |
| Piramal Critical Care | $122.70 | 2023-2025 | |
| Ipsen Biopharmaceuticals, INC | $43.93 | 2019-2022 | |
| Trice Medical, INC. | $37.30 | 2024 | |
| Saol Therapeutics INC. | $34.62 | 2019 | |
| Teva Pharmaceuticals USA, INC. | $23.77 | 2023 | Austedo Xr |
| Tersera Therapeutics LLC | $21.93 | 2024 | Prialt |
| Pacira Therapeutics, INC. | $21.54 | 2019 | |
| Amgen INC. | $19.11 | 2019 | |
| Otsuka America Pharmaceutical, INC. | $16.27 | 2024 | Nuedexta |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Scilex Pharmaceuticals INC. | $15.43 | 2019 | |
| Novartis Pharmaceuticals Corporation | $14.65 | 2020 | |
| Ermi LLC | $13.35 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ari Kriswari listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.